Cytokinetics, Inc. (Nasdaq: CYTK) announced that the Federal Trade Commission has granted early termination of the waiting period under the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE